» Articles » PMID: 32440131

Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study

Overview
Publisher Dove Medical Press
Specialty Psychiatry
Date 2020 May 23
PMID 32440131
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Antidepressant consumption has risen in recent years, driven by longer treatment duration. The objective of this study was to measure the prevalence of antidepressant long-term and chronic use in the Bologna area, Italy, and to identify their main determinants.

Materials And Methods: We conducted a retrospective claims-based cohort study by using the Bologna Local Health Authority data. A cohort of 18,307 incident users of antidepressant drugs in 2013 was selected, and subjects were followed for three years. A long-term utilization was defined as having at least one prescription claimed during each year of follow-up, while chronic utilization was defined as claiming at least 180 defined daily doses per year. Factors associated with chronic and long-term use were identified by univariate and multivariate logistic regressions.

Results: In our cohort, 5448 (29.8%) and 1817 (9.9%) subjects were dispensed antidepressants for a long-term course and in a chronically way, respectively. Older age, antidepressant polytherapy, polypharmacy, and being prescribed the first antidepressant by a hospital physician were all factors independently associated with chronic and long-term prescriptions of antidepressant drugs. Results were reported separately for men and women.

Conclusion: Antidepressant long-term and chronic prescriptions are common in the Bologna area. Because longer treatment should be clinically motivated, these results strongly prompt the need to evaluate the actual relevance, as they may indicate potentially inappropriate prescription patterns.

Citing Articles

Uncovering antidepressant prescription patterns: a three-year analysis of outpatient trends.

Karami H, Mehrizi R, Effatpanah M, Rivandi A, Daroudi R, Armand N BMC Psychiatry. 2025; 25(1):90.

PMID: 39901169 PMC: 11792704. DOI: 10.1186/s12888-025-06521-z.


Potential deprescribing indications for antidepressants between 2012 and 2019: repeated cross-sectional analysis in two Scottish health boards.

Brisnik V, Rottenkolber M, Vukas J, Schechner M, Lukaschek K, Jung-Sievers C BMC Med. 2024; 22(1):378.

PMID: 39256761 PMC: 11389559. DOI: 10.1186/s12916-024-03584-9.


Use and misuse of psychoactive medicines: a descriptive cross-sectional study in a densely populated region of Portugal.

Araujo A, Guerreiro J, Bulhosa C, Alves da Costa F, Goulao J, Martins A J Pharm Policy Pract. 2024; 17(1):2369319.

PMID: 39081707 PMC: 11288207. DOI: 10.1080/20523211.2024.2369319.


Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness Method.

Brisnik V, Vukas J, Jung-Sievers C, Lukaschek K, Alexander G, Thiem U BMC Med. 2024; 22(1):193.

PMID: 38735930 PMC: 11089726. DOI: 10.1186/s12916-024-03397-w.


Prevalence of antidepressant use in Brazil: a systematic review with meta-analysis.

Tiguman G, Hoefler R, Silva M, Lima V, Ribeiro-Vaz I, Galvao T Braz J Psychiatry. 2023; 46:e20233095.

PMID: 37718462 PMC: 11189131. DOI: 10.47626/1516-4446-2023-3095.


References
1.
Petty D, House A, Knapp P, Raynor T, Zermansky A . Prevalence, duration and indications for prescribing of antidepressants in primary care. Age Ageing. 2006; 35(5):523-6. DOI: 10.1093/ageing/afl023. View

2.
Lunghi C, Zongo A, Moisan J, Gregoire J, Guenette L . Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression. J Diabetes Complications. 2017; 31(7):1200-1206. DOI: 10.1016/j.jdiacomp.2017.02.016. View

3.
Verbeek-Heida P, Mathot E . Better safe than sorry--why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study. Chronic Illn. 2006; 2(2):133-42. DOI: 10.1177/17423953060020020801. View

4.
Wong J, Motulsky A, Abrahamowicz M, Eguale T, Buckeridge D, Tamblyn R . Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system. BMJ. 2017; 356:j603. PMC: 5320934. DOI: 10.1136/bmj.j603. View

5.
Baxter A, Vos T, Scott K, Ferrari A, Whiteford H . The global burden of anxiety disorders in 2010. Psychol Med. 2014; 44(11):2363-74. DOI: 10.1017/S0033291713003243. View